Paradoxical action of growth factors: antiproliferative and proapoptotic signaling by HGF/c-MET
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Paradoxical action of growth factors: antiproliferative and proapoptotic signaling by HGF/c-MET
Authors
Keywords
-
Journal
GROWTH FACTORS
Volume 29, Issue 4, Pages 105-118
Publisher
Informa UK Limited
Online
2011-06-03
DOI
10.3109/08977194.2011.585609
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mechanisms and functions of p38 MAPK signalling
- (2010) Ana Cuadrado et al. BIOCHEMICAL JOURNAL
- Bid Stands at the Crossroad of Stress-Response Pathways
- (2010) G. Song et al. CURRENT CANCER DRUG TARGETS
- Novel Proapoptotic Effect of Hepatocyte Growth Factor: Synergy with Palmitate to Cause Pancreatic β-Cell Apoptosis
- (2010) José A. González-Pertusa et al. ENDOCRINOLOGY
- Inhibition of Met/HGF receptor and angiogenesis by NK4 leads to suppression of tumor growth and migration in malignant pleural mesothelioma
- (2010) Yoshinori Suzuki et al. INTERNATIONAL JOURNAL OF CANCER
- Celastrol, a Triterpene, Enhances TRAIL-induced Apoptosis through the Down-regulation of Cell Survival Proteins and Up-regulation of Death Receptors
- (2010) Bokyung Sung et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Disintegrin and Metalloproteinase-10 (ADAM-10) Mediates DN30 Antibody-induced Shedding of the Met Surface Receptor
- (2010) Florian Schelter et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MET signalling: principles and functions in development, organ regeneration and cancer
- (2010) Livio Trusolino et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Structural basis for agonism and antagonism of hepatocyte growth factor
- (2010) W. D. Tolbert et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Alternative Proteolytic Processing of Hepatocyte Growth Factor during Wound Repair
- (2009) Nils Buchstein et al. AMERICAN JOURNAL OF PATHOLOGY
- Scatter factor protects tumor cells against apoptosis caused by TRAIL
- (2009) Saijun Fan et al. ANTI-CANCER DRUGS
- Deletion of the ectodomain unleashes the transforming, invasive, and tumorigenic potential of theMEToncogene
- (2009) Simone Merlin et al. CANCER SCIENCE
- Phosphorylation of the MET receptor on juxtamembrane tyrosine residue 1001 inhibits its caspase-dependent cleavage
- (2009) Julien Deheuninck et al. CELLULAR SIGNALLING
- Life and death by death receptors
- (2009) Maria Eugenia Guicciardi et al. FASEB JOURNAL
- EGF receptor in relation to tumor development: molecular basis of responsiveness of cancer cells to EGFR-targeting tyrosine kinase inhibitors
- (2009) Kenji Takeuchi et al. FEBS Journal
- Angioinhibitory Action of NK4 Involves Impaired Extracellular Assembly of Fibronectin Mediated by Perlecan-NK4 Association
- (2009) Katsuya Sakai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Down-Regulation of the Met Receptor Tyrosine Kinase by Presenilin-dependent Regulated Intramembrane Proteolysis
- (2009) Bénédicte Foveau et al. MOLECULAR BIOLOGY OF THE CELL
- Id1 Is Down-Regulated by Hepatocyte Growth Factor via ERK-Dependent and ERK-Independent Signaling Pathways, Leading to Increased Expression of p16INK4a in Hepatoma Cells
- (2009) K. Ushio et al. MOLECULAR CANCER RESEARCH
- Proteolytic cleavages give receptor tyrosine kinases the gift of ubiquity
- (2009) F Ancot et al. ONCOGENE
- Crosstalk in Met receptor oncogenesis
- (2009) Andrea Z. Lai et al. TRENDS IN CELL BIOLOGY
- Developing c-MET pathway inhibitors for cancer therapy: progress and challenges
- (2009) Xiangdong Liu et al. TRENDS IN MOLECULAR MEDICINE
- NK3 and NK4 of HGF enhance filamin production via STAT pathway, but not NK1 and NK2 in human breast cancer cells
- (2008) Ya-ling LIN et al. ACTA PHARMACOLOGICA SINICA
- Caspase cleavage of the MET receptor generates an HGF interfering fragment
- (2008) Julien Deheuninck et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Hepatocyte growth factor enhances death receptor-induced apoptosis by up-regulating DR5
- (2008) Yang Li et al. BMC CANCER
- A novel and effective hepatocyte growth factor kringle 1 domain and p53 cocktail viral gene therapy for the treatment of hepatocellular carcinoma
- (2008) Zan Shen et al. CANCER LETTERS
- MET receptor tyrosine kinase as a therapeutic anticancer target
- (2008) Christine M. Stellrecht et al. CANCER LETTERS
- "Active" Cancer Immunotherapy by Anti-Met Antibody Gene Transfer
- (2008) E. Vigna et al. CANCER RESEARCH
- The Kringle 1 Domain of Hepatocyte Growth Factor Has Antiangiogenic and Antitumor Cell Effects on Hepatocellular Carcinoma
- (2008) Z. Shen et al. CANCER RESEARCH
- Interaction between ERK and GSK3β Mediates Basic Fibroblast Growth Factor-induced Apoptosis in SK-N-MC Neuroblastoma Cells
- (2008) Cuiling Ma et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Engineering the NK1 Fragment of Hepatocyte Growth Factor/Scatter Factor as a MET Receptor Antagonist
- (2008) Mark Youles et al. JOURNAL OF MOLECULAR BIOLOGY
- Drug development of MET inhibitors: targeting oncogene addiction and expedience
- (2008) Paolo M. Comoglio et al. NATURE REVIEWS DRUG DISCOVERY
- The promise of cancer therapeutics targeting the TNF-related apoptosis-inducing ligand and TRAIL receptor pathway
- (2008) S Wang ONCOGENE
- JNK signaling in apoptosis
- (2008) D N Dhanasekaran et al. ONCOGENE
- Up-regulation of p21CIP1 expression mediated by ERK-dependent and -independent pathways contributes to hepatocyte growth factor-induced inhibition of HepG2 hepatoma cell proliferation
- (2007) Erika Shirako et al. JOURNAL OF CELLULAR BIOCHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started